...
首页> 外文期刊>Laws >Labeling Genetically Engineered Food in the United States: Suggestions for a New Approach
【24h】

Labeling Genetically Engineered Food in the United States: Suggestions for a New Approach

机译:在美国标记基因工程食品:对新方法的建议

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The Federal Food, Drug, and Cosmetic Act (FFDCA) provides that a food is misbranded if the label accompanying the product is false or misleading in any particular. Congress provided minimal guidance to assist the FDA in making these determinations. When challenged, courts have granted substantial deference to FDA’s various interpretations of what constitute a material fact. However, when confronted with the regulatory question of whether or how to label products derived from genetically engineered (GE) crops, the FDA adopted a narrow reading of the statute that focused on changes in the product itself, rather than the act of genetic engineering. Only those GE products that possessed characteristics significantly different from their conventional counterparts would require labels. This “process versus product” distinction in food labels lies at the heart of the FDA’s resistance to repeated calls for mandatory labeling of foods derived from genetic engineering. Consumer interest in GE food, according to the agency, is not a material fact to trigger mandatory labeling under the statute. In contrast to its approach to GE labels, the agency has long required (since 1966) process-based labels for foods treated with irradiation. As recently as 1986, the FDA affirmed that materiality of information under it misbranding analysis is not limited to product safety or even the abstract worth of the information, but whether consumers view the information as important and whether the omission of a labeling statement would mislead the consumer. Accordingly, mere consumer interest can give rise to a mandatory labeling regime under the FFDCA. In the irradiation context, whole foods and single-ingredient products treated with irradiation must bear a label indicating the process. The irradiation of components in a multi-ingredient food product, however, need not bear a label. This distinction between processed, multi-ingredient and whole or single-ingredient foods provides a potential pathway for the agency to revise its approach to mandatory GE labeling. Exempting highly processed, multi-ingredient foods from a labeling regime would minimize traceability and segregation-generated disruptions in the commodity supply chain, thereby minimizing potential compliance costs, while also empowering consumers to express their preferences for non-GE whole and single-ingredient food products.
机译:联邦食品,药品和化妆品法(FFDCA)规定,如果产品随附的标签有任何虚假或误导性标签,则该食品应贴错标签。国会提供了最少的指导来帮助FDA做出这些决定。当受到质疑时,法院已大大尊重FDA对构成实质性事实的各种解释。但是,当面对有关是否或如何标记来自基因工程作物的产品的监管问题时,FDA采取了狭义的法规,该法规侧重于产品本身的变化,而不是基因工程的行为。只有那些具有与常规产品明显不同的特性的GE产品才需要标签。食品标签中“工艺与产品”的区别是FDA拒绝重复要求对基因工程食品进行强制标签的核心原因。据该机构称,消费者对GE食品的兴趣并不是根据法规触发强制性标签的重要事实。与采用GE标签的方法相反,该机构长期以来(自1966年以来)一直要求对辐照处理过的食品使用基于过程的标签。直到1986年,FDA才确认在其错误贴标分析中所包含的信息的重要性不仅限于产品安全性,甚至不限于信息的抽象价值,而是消费者是否认为该信息很重要以及遗漏标签说明是否会误导消费者。消费者。因此,仅消费者的利益就可以根据FFDCA制定强制性标签制度。在辐照的情况下,经过辐照处理的整个食品和单一成分产品必须带有标明该过程的标签。但是,多成分食品中成分的辐照不需要带有标签。加工食品,多成分食品和全成分或单成分食品之间的区别为FDA修改其强制性GE标签方法提供了一条潜在途径。从标签制度中免除高度加工的,多成分的食品将最大程度地减少可追溯性和隔离造成的商品供应链中断,从而将潜在的合规成本降至最低,同时还使消费者能够表达对非转基因全脂和单一成分食品的偏好产品。

著录项

  • 来源
    《Laws》 |2013年第3期|共19页
  • 作者

    A. Bryan Endres;

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种
  • 中图分类 法律;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号